Cancer cells being destroyed by immunotherapy.
(Source: Adobe Stock)

Discover BioVaxys’ innovative DPX™ platform, a cutting-edge lipid-based delivery system transforming immunotherapy. This video explores how the company’s proprietary technology encapsulates diverse bioactive molecules, enhancing and sustaining immune responses. Learn how BioVaxys is leveraging this groundbreaking platform to potentially revolutionize vaccines and treatments.

To keep up with the latest developments from the company, visit https://www.biovaxys.com/

This is third-party content provided by BioVaxys Technology Corp. (CSE:BIOV). Please see full disclaimer here.

Join the discussion: Find out what everybody’s saying about this company on the BioVaxys Technology Corp. Bullboard investor discussion forum, and check out the rest of Stockhouse’s stock forums and message boards.

(Top photo: Adobe Stock)

More From The Market Online

The world’s first quantum computing Super Hub opens in Alberta

SuperQ (CSE:QBTQ) opens the world’s first quantum computing Super Hub at the Tecconnect Innovation Centre in Lethbridge, Alberta.

@ the Bell: Markets fall despite easing inflation concerns

Canada’s main stock index moved lower on Tuesday, with gold sector stocks leading the drop. This...